AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Unraveling Alzheimer's Research Misconduct
This chapter investigates the development of the Alzheimer's drug semifilum by Cassava Sciences, uncovering issues of manipulated data and misconduct. It sheds light on the FDA's awareness of these problems, the impact of the amyloid hypothesis on research, and the prevalence of doctored images in scientific studies. The discussion reveals the consequences of confirmation bias and the risk it poses to the integrity of Alzheimer's research.